|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 39/39558 | (2013.01) | ||
| C07K 16/2887 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/41 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| C12Q 1/6886 | (2013.01) | ||
| C12Q2600/106 | (2013.01) | ||
| C12Q2600/158 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| G01N 33/57426 | (2013.01) | ||
| G01N2333/70596 | (2013.01) | ||
| G01N2800/52 | (2013.01) |
| (11) | Patento numeris | 3665196 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18755421.7 |
| Europos patento paraiškos padavimo data | 2018-08-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-06-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/071462 |
| Data | 2018-08-08 |
| (87) | Numeris | WO 2019/030260 |
| Data | 2019-02-14 |
| (30) | Numeris | Data | Šalis |
| 201762542489 P | 2017-08-08 | US |
| (72) |
OESTERGAARD, Mikkel Zahle , CH
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
NanoString Technologies, Inc. , 530 Fairview Ave North, Seattle, WA 98109, US |
| (54) | OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP |
| OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP |